Published in Acta Physiol Scand on June 01, 1970
Classification of hyperlipidaemias and hyperlipoproteinaemias. Bull World Health Organ (1970) 5.58
Ischaemic heart-disease in relation to fasting values of plasma triglycerides and cholesterol. Stockholm prospective study. Lancet (1972) 4.54
The prostaglandins: a family of biologically active lipids. Pharmacol Rev (1968) 3.85
Risk factors for ischaemic heart-disease in normal men aged 40. Edinburgh-Stockholm Study. Lancet (1978) 2.32
Stimulation of fecal steroid excretion after infusion of recombinant proapolipoprotein A-I. Potential reverse cholesterol transport in humans. Circulation (1999) 2.27
Concentration of triglycerides, phospholipids and glycogen in skeletal muscle and of free fatty acids and beta-hydroxybutyric acid in blood in man in response to exercise. Eur J Clin Invest (1971) 1.62
Cardiovascular and metabolic response to infusions of prostaglandin E1 and to simultaneous infusions of noradrenaline and prostaglandin E1 in man. Prostaglandin and related factors 35. Acta Physiol Scand (1965) 1.52
Risk factors for myocardial infarction in the Stockholm prospective study. A 14-year follow-up focussing on the role of plasma triglycerides and cholesterol. Acta Med Scand (1979) 1.44
Hyper- -lipoproteinemia in men exposed to chlorinated hydrocarbon pesticides. Acta Med Scand (1972) 1.40
Nicotinic acid treatment shifts the fibrinolytic balance favourably and decreases plasma fibrinogen in hypertriglyceridaemic men. J Cardiovasc Risk (1997) 1.40
Comparison between the use of isopropanol and tetramethylurea for the solubilisation and quantitation of human serum very low density apolipoproteins. Anal Biochem (1978) 1.38
Effect of combined clofibrate--nicotinic acid treatment in ischemic heart disease. Atherosclerosis (1980) 1.36
High density lipoproteins and coronary atherosclerosis. A strong inverse relation with the largest particles is confined to normotriglyceridemic patients. Arterioscler Thromb (1991) 1.34
Application of a new intravenous fat tolerance test in the study of hypertriglyceridaemia in man. J Atheroscler Res (1969) 1.34
Inhibition of the mobilization of free fatty acids from adipose tissue. Physiological aspects on the mechanisms for the inhibition of mobilization of FFA from adipose tissue. Ann N Y Acad Sci (1965) 1.23
Fish-eye disease. A new familial condition with massive corneal opacities and dyslipoproteinaemia. Lancet (1979) 1.19
Circulatory and respiratory effects of different doses of prostaglandin E1 in man. Acta Physiol Scand (1969) 1.18
Intravenous prostaglandin E1 in severe peripheral vascular disease. Lancet (1976) 1.17
Clinical, hemodynamic and metabolic effects of intraarterial infusions of prostaglandin E1 in patients with peripheral vascular disease. Adv Prostaglandin Thromboxane Res (1976) 1.17
Grounding spatial language in perception: an empirical and computational investigation. J Exp Psychol Gen (2001) 1.13
Determination of the intravenous fat tolerance test with intralipid by nephelometry. Atherosclerosis (1972) 1.11
Effect of chlorophenoxyisobutyric acid (CPIB) on fat-mobilizing lipolysis and cyclic AMP levels in rat epididymal fat. Atherosclerosis (1973) 1.10
Effect of prostaglandin E1 on blood pressure and heart rate in the dog. Prostaglandin and related factors 48. Acta Physiol Scand (1966) 1.09
Changing relative proportions of apolipoproteins CII and CIII of very low density lipoproteins in hypertriglyceridaemia. Atherosclerosis (1976) 1.08
Low A-esterase activity in serum of patients with fish-eye disease. Clin Chem (1987) 1.08
Relationship in man between plasma free fatty acids and myocardial metabolism of carbohydrate substrates. Lancet (1971) 1.07
Quantitative and qualitative serum lipoprotein analysis. Part 1. Studies in healthy men and women. Atherosclerosis (1975) 1.06
Serum lipids, intravenous glucose tolerance and their interrelation studied in ischaemic cardiovascular disease. Acta Med Scand (1966) 1.05
Reduction of myocardial reinfarction by the combined treatment with clofibrate and nicotinic acid. Atherosclerosis (1977) 1.05
Lipoprotein metabolism in hepatic lipase deficiency: studies on the turnover of apolipoprotein B and on the effect of hepatic lipase on high density lipoprotein. J Lipid Res (1988) 1.04
Femoral-artery infusion of prostaglandin E 1 in severe peripheral vascular disease. Lancet (1973) 1.04
Determination of splanchnic secretion rate of plasma triglycerides and of total and splanchnic turnover of plasma free fatty acids in man. Eur J Clin Invest (1972) 1.03
Acute effects of nicotinic acid on plasma, liver, heart and muscle lipids. Nicotinic acid in the rat. II. Acta Med Scand (1966) 1.02
Studies on burns. XII. Lipid metabolism, catecholamine excretion, basal metabolic rate, and water loss during treatment of burns with warm dry air. Acta Chir Scand (1972) 1.02
Deficiency of hepatic lipase activity in post-heparin plasma in familial hyper-alpha-triglyceridemia. Acta Med Scand (1986) 1.01
Myocardial lipid and carbohydrate metabolism in healthy, fasting men at rest: studies during continuous infusion of 3 H-palmitate. Eur J Clin Invest (1972) 1.01
Fish eye disease: a new familial condition with massive corneal opacities and dyslipoproteinaemia. Eur J Clin Invest (1982) 1.00
Lipid metabolism and trauma. 3. Plasma lipids and lipoproteins in burns. Acta Med Scand (1965) 1.00
Changes in plasma very low density and low density lipoprotein content, composition, and size after a fatty meal in normo- and hypertriglyceridemic man. J Lipid Res (1979) 1.00
A case of massive hypertriglyceridemia corrected by nicotinic acid or nicotinamide therapy. Atherosclerosis (1973) 0.97
Regression of computer estimated femoral atherosclerosis after pronounced serum lipid lowering in patients with asymptomatic hyperlipidaemia. Lancet (1982) 0.96
Relationship between plasma plasminogen activator inhibitor-1 activity and VLDL triglyceride concentration, insulin levels and insulin sensitivity: studies in randomly selected normo- and hypertriglyceridaemic men. Diabetologia (1993) 0.96
Frequency of ischaemic exercise E.C.G. Changes in symptom-free men with various forms of primary hyperlipaemia. Lancet (1975) 0.95
Effect of infusion of prostaglandin E1 on the aggregation of blood platelets in man. Life Sci (1968) 0.95
Effect of different doses of prostaglandin E on free fatty acids of plasma, blood glucose and heart rate in the nonanesthetized dog. Prostaglandin and related factors 53. Acta Physiol Scand (1966) 0.95
Ischaemic heart disease and associated risk factors in 40 year old men in Edinburgh and Stockholm. Eur J Clin Invest (1975) 0.94
Turnover of 131-I-labelled fibrinogen in man. Studies in normal subjects, in congenital coagulation factor deficiency states, in liver cirrhosis, in polycythemia vera and in epidermolysis bullosa. Acta Med Scand (1966) 0.94
Splanchnic secretion rates of plasma triglycerides and total and splanchnic turnover of plasma free fatty acids in men with normo- and hypertriglyceridaemia. Eur J Clin Invest (1972) 0.94
Effect of nicotinic acid on plasma lipids in patients with hyperlipoproteinemia during the first week of treatment. J Atheroscler Res (1968) 0.93
Relationships of low density lipoprotein subfractions to angiographically defined coronary artery disease in young survivors of myocardial infarction. Atherosclerosis (1991) 0.93
Risk factors for ischaemic heart disease in men and women. Results of the 19-year follow-up of the Stockholm Prospective Study. Acta Med Scand (1985) 0.93
Clinical and metabolic effects of different doses of prostaglandin E1 in man. Prostaglandin and related factors. Acta Med Scand (1968) 0.92
Myocardial lipid and carbohydrate metabolism in fasting men during prolonged exercise. J Appl Physiol (1972) 0.92
Plasma or patient, paper electrophoresis or physician? the four-P problem in classification of hyperlipidaemia. Atherosclerosis (1971) 0.92
Fatty acids incorporation into human adipose tissue in hypertriglyceridaemia. Eur J Clin Invest (1976) 0.91
Basal lipolysis and effects of norepinephrine and prostaglandin E on lipolysis in human subcutaneous and omental adipose tissue. J Lab Clin Med (1968) 0.91
Plasma lipids and urinary excretion of catecholamines in man during experimentally induced emotional stress, and their modification by nicotinic acid. J Clin Invest (1968) 0.90
Dissociation of the effects of nicotinic acid on vasodilatation and lipolysis by a prostaglandin synthesis inhibitor, indomethacin, in man. Med Biol (1979) 0.90
Mobilization and utilization of lipids after trauma: relation to caloric homeostasis. In: Energy metabolism in trauma. Ciba Found Symp (1970) 0.90
Effects of an oral contraceptive agent on plasma lipids, plasma lipoproteins, the intravenous fat tolerance and the post-heparin lipoprotein lipase activity. Acta Med Scand (1971) 0.90
Increased removal rate of exogenous triglycerides after prolonged exercise in man: time course and effect of exercise duration. Metabolism (1987) 0.89
Effect of a single dose of nicotinic acid on plasma lipids in patients with hyperlipoproteinemia. Acta Med Scand (1968) 0.88
Stimulatory effect of ethanol on glycerol release from rat adipose tissue in vitro. Life Sci (1965) 0.88
Quantitative and qualitative serum lipoprotein analysis. Part 2. Studies in male survivors of myocardial infarction. Atherosclerosis (1975) 0.87
The role of fatty acid and of hormones in the determination of myocardial carbohydrate metabolism in healthy fasting men. Eur J Clin Invest (1973) 0.87
Fatty acids as a determinant of myocardial substrate and oxygen metabolism in man at rest and during prolonged exercise. Acta Med Scand (1973) 0.87
A note on the cardiovascular and metabolic effects of prostaglandin A-1. Prostaglandin and related factors 61. Life Sci (1967) 0.87
Serotonin syndrome caused by interaction between citalopram and fentanyl. J Clin Pharm Ther (2007) 0.86
Plasma beta-hydroxybutyric acid response to nicotinic acid-induced plasma free fatty acid decrease in man. Diabetologia (1966) 0.86
Effect of probucol treatment on the susceptibility of low density lipoprotein isolated from hypercholesterolemic patients to become oxidatively modified in vitro. Atherosclerosis (1990) 0.86
Effect of different doses of vitamin D on serum cholesterol and triglyceride levels in healthy men. Atherosclerosis (1971) 0.86
The Stockholm prospective study. 1. The initial values for plasma lipids. Acta Med Scand Suppl (1968) 0.86
Quantitative studies on the lipolytic response of human subcutaneous and omental adipose tissue to noradrenaline and theophylline. Acta Med Scand (1969) 0.86
Paradoxical esterification of plasma cholesterol in fish eye disease. Acta Med Scand (1985) 0.86
Treatment of hyperlipoproteinemia (HLP) type II A with a new phenoxy-isobuturic acid derivative, procetofen. Int J Clin Pharmacol Biopharm (1979) 0.85
A case of massive hypertriglyceridaemia and impaired fatty acid incorporation into adipose tissue glycerides (FIAT), both corrected by nicotinic acid. Acta Med Scand (1973) 0.85
Differences in heparin-released lipolytic activity in the superficial and deep veins of the human forearm. Eur J Clin Invest (1977) 0.85
Extraction of lipids from human whole serum and lipoproteins and from rat liver tissue with methylene chloride-methanol: a comparison with extraction with chloroform-methanol. Clin Chim Acta (1985) 0.85
Plasma lipid metabolism at trauma: appearance of characteristic apolipoproteins in high density lipoproteins. Acta Chir Scand Suppl (1985) 0.85
On the rise in low density and high density lipoproteins in response to the treatment of hypertriglyceridaemias in type IV and type V hyperlipoproteinaemias. Atherosclerosis (1977) 0.85
Serum cholesterol and cancer--a retrospective case-control study. Int J Epidemiol (1986) 0.85
Nicotinic acid and inhibition of fat mobilizing lipolysis. Present status of effects on lipid metabolism. Adv Exp Med Biol (1978) 0.85
Effects of secretin on fat mobilizing lipolysis and cyclic AMP levels in rat adipose tissue. Acta Physiol Scand (1970) 0.84
Lipid metabolism and trauma. IV. Effect of treatment with intravenous fat emulsion on plasma lipids, proteins and clinical condition of burned patients. Acta Chir Scand (1971) 0.84
Effect of nicotinic acid on myocardial metabolism in man at rest and during exercise. J Appl Physiol (1972) 0.84
Prostacyclin production augmented in the short term by nicotinic acid. Lancet (1983) 0.84
Risk factors for death for males and females. A study of the death pattern in the Stockholm prospective study. Acta Med Scand (1982) 0.84
Lipoprotein alterations and plasma lipoprotein lipase reduction in familial hemophagocytic lymphohistiocytosis. Acta Paediatr Scand (1991) 0.83
Serum-enzyme activities, cholesterin, and triglycerides in serum after intake of alcohol. Scand J Clin Lab Invest Suppl (1966) 0.83
Angioplasty or stent placement in the proximal common iliac artery: is protection of the contralateral side necessary? J Vasc Interv Radiol (2001) 0.83
The effects of nicotinic acid treatment on high density lipoprotein particle size subclass levels in hyperlipidaemic subjects. Atherosclerosis (1990) 0.83
Evidence for deficiency of high density lipoprotein lecithin: cholesterol acyltransferase activity (alpha-LCAT) in fish eye disease. Acta Med Scand (1985) 0.83
Composition, concentration, and size of low density lipoproteins and of subfractions of very low density lipoproteins from serum of normal men and women. J Lipid Res (1982) 0.83
High density lipoprotein particle size distribution in cord blood. Acta Paediatr Scand (1992) 0.83
Effects of oral calcium upon serum cholesterol and triglycerides in patients with hyperlipidemia. Atherosclerosis (1972) 0.83
Hypertriglyceridemia--acute pancreatitis--ischemic heart disease. A case study in a pair of monozygotic twins. Acta Med Scand (1987) 0.82
[Maximum gastric stimulation with the augmented histamine test in healthy children]. Helv Paediatr Acta (1969) 0.82
Potential hypolipidemic agents. 7. Synthesis and lipid-lowering properties of 2-(dibenzofuranyloxy)-2-methylpropionates and related compounds. J Med Chem (1974) 0.82